Groningen

• GRoningen Early-PD Ambroxol Treatment Pharmacokinetics Pending
  2024-519088-16-01 3 Parkinson's disease
• A PHASE 1 STUDY WITH SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND FOOD EFFECT OF LMT503 IN HEALTHY SUBJECTS. Pending
  2024-519180-17-00 1 Healthy volonteers
• A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel … Pending
  2024-519786-22-01 9 metastatic non-small cell lung cancer (NSCLC)
• A trial to learn how well sonesitatug vedotin and capecitabine with or without rilvegostomig work and how safe they are in adults with cance … Pending
  2024-519787-40-00 5 Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal C
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o … Pending
  2025-521632-12-00 5 Patients on Factor Xa inhibitor treatment needing an urgent interventi
• Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation Pending
  2025-522027-95-00 5 oral squamous cell carcinoma
• REVITALISE Study Pending
  2025-522060-32-00 4 STEMI (ST elevated Myocardial Infarction)
• A single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small … Pending
  2025-522162-75-00 4 patients with asymptomatic active brain metastases from small cell lun
• CANagliflozin In DIAlysis Patients Pending
  2025-522742-46-00 6 Chronic Kidney disease
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L … Pending
  2025-522818-23-00 5 Small Cell Lung Cancer (SCLC)
• Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants Pending
  2025-522935-32-00 3 interstitial cystitis/bladder pain syndrome
• Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc) Pending
  2025-523288-39-00 4 Diffuse Cutaneous Systemic Sclerosis (dcSSc)
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• A study in healthy men to test how BI 1815368 is processed in the body Pending
  2025-523949-10-00 3 Healthy volunteers trial
• Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an … Pending
  2025-524229-41-00 5 Triple negative breast cancer
• HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of ve … Pending
  2025-524283-38-00 5 Relapsed or refractory chronic lymphocytic leukemia
• GRAIN, Prospective Pilot Study Pending
  2025-524470-41-00 1 Esophageal adenocarcinoma
• A study investigating the safety and efficacy of academically-produced CAR T cells compared with standard treatment for patients with multip … Pending
  2025-524876-43-00 5 relapsed/refractory multiple myeloma
• A First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MR-L45 in Healthy Adults Pending
  2025-524899-40-00 1 Autosomal Dominant Polycystic Kidney Disease
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD) Pending
  2025-525068-13-00 4 Chronic Kidney Disease

Showing 25–48 of 689 trials